<DOC>
	<DOCNO>NCT00007917</DOCNO>
	<brief_summary>Phase I trial study effectiveness gemcitabine plus flavopiridol treating patient advance solid tumor . Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell .</brief_summary>
	<brief_title>Gemcitabine Plus Flavopiridol Treating Patients With Advanced Solid Tumors</brief_title>
	<detailed_description>OBJECTIVES : I . Determine maximum tolerate dose gemcitabine flavopiridol patient advance solid tumor . II . Determine toxicity safety profile regimen patient . III . Determine pharmacokinetic profile regimen patient population . OUTLINE : This dose-escalation study . Patients receive gemcitabine IV 1-2.5 hour day 1 8 flavopiridol IV continuously 24 hour day 2 9 . Courses repeat every 21 day absence disease progression unacceptable toxicity . Cohorts 3-6 patient receive escalate dos gemcitabine flavopiridol maximum tolerate dose ( MTD ) reach . The MTD define dose precede 2 3 2 6 patient experience dose-limiting toxicity . PROJECTED ACCRUAL : Approximately 6-58 patient accrue study .</detailed_description>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Alvocidib</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven solid tumor gemcitabine treatment option effective therapy exist Previously untreated disease allow No large potentially symptomatic pericardial effusion undrained pleural effusion ( without pleurodesis ) No CNS metastases PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 02 Life expectancy : At least 12 week Hematopoietic : Absolute neutrophil count least 2,000/mm3 Platelet count least 100,000/mm3 No prior thrombotic event Hepatic : Bilirubin great 1.5 mg/dL SGOT great 2 time upper limit normal Renal : Creatinine great 1.5 mg/dL Cardiovascular : No clinically significant cardiac disease No prior deep venous thrombus No prior arterial vascular event No prior myocardial infarction No unstable angina No prior transient ischemic attack cerebrovascular accident No cardiac arrhythmia could relate cardiac ischemia Pulmonary : No clinically significant pulmonary disease No history pulmonary embolism Other : Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No active infection No severe malnutrition intractable emesis No chronic diarrheal disease within past 6 month PRIOR CONCURRENT THERAPY : Chemotherapy : No 1 prior chemotherapy regimen At least 3 week since prior chemotherapy ( 6 week nitrosoureas mitomycin ) recover Prior gemcitabine flavopiridol allow No concurrent chemotherapy Radiotherapy : At least 3 week since prior radiotherapy recover No prior radiotherapy 50 % bone marrow No concurrent radiotherapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
</DOC>